Black Diamond Therapeutics Stock Performance
as on March 14, 2026 at 6:59 am IST
Day's Low
Day's High
$2.07$2.22
2.82%
Downside
4.23%
Upside
52 Week's Low
52 Week's High
$1.20$4.9443.90%
Downside
131.92%
Upside
Black Diamond Therapeutics share price movements today
- Previous Close
- $2.13
- Open
- $2.14
- Volume
- 1.6M
- Day's Low - High
- $2.07 - $2.22
- 52 Week Low - High
- $1.20 - $4.94
Black Diamond Therapeutics Historical Returns
- 1 Month Return
- -4.5 %
- 3 Month Return
- -24.01 %
- 1 Year Return
- + 23.26 %
- 3 Year Return
- + 21.84 %
- 5 Year Return
- -92 %
Black Diamond Therapeutics Stock Fundamentals & Key Indicators
Check Black Diamond Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$121.4M
EPS (TTM)
0.4217
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
5.76
Industry PE ratio
-3.3382638888888887
PEG Ratio
0EBITDA
15.1M
Revenue (TTM)
70.0M
Profit Margin
30.71%
Return On Equity TTM
19.23%
Black Diamond Therapeutics Stock Valuation
Track how Black Diamond Therapeutics P/E has moved over time to understand its valuation trends.
Black Diamond Therapeutics in the last 5 years
Lowest (-11.33x)
March 31, 2021
Industry (-3.34x)
March 14, 2026
Today (5.76x)
March 14, 2026
Highest (32.41x)
March 31, 2025
Today’s Price to Earnings Ratio: 5.76x
Black Diamond Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Black Diamond Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $121.4M | -92% | 5.76 | 30.71% | |
| BUY | $42.1B | 120.4% | 136.74 | 8.45% | |
| BUY | $121.4B | 118.98% | 31.23 | 32.94% | |
| NA | $33.0B | NA | 115.04 | 5.37% | |
| BUY | $78.9B | 58.18% | 17.99 | 31.41% |
Stock Returns calculator for Black Diamond Therapeutics Stock including INR - Dollar returns
The Black Diamond Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Black Diamond Therapeutics investment value today
Current value as on today
₹1,30,168
Returns
₹30,168
(+30.17%)
Returns from Black Diamond Therapeutics Stock
₹23,837 (+23.84%)
Dollar Returns*
₹6,330 (+6.33%)
Analyst Recommendation on Black Diamond Therapeutics Stock
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Black Diamond Therapeutics. Average target price of $9.29
Black Diamond Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Black Diamond Therapeutics.
What analysts predicted
77.07%UPSIDE
Target Price
$9.29
Current Price
$2.13
Analyzed by
12 Analysts
Target
$9.29
Black Diamond Therapeutics target price $9.29, a slight upside of 77.07% compared to current price of $2.13. According to 12 analysts rating.
Black Diamond Therapeutics Stock’s Investor Sentiment and Interest
Search interest for Black Diamond Therapeutics Stock has increased by 36% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:36% versus previous 30 day period
Black Diamond Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Black Diamond Therapeutics Annual Profit & Loss
All numbers in Millions USD
Black Diamond Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Black Diamond Therapeutics Annual Cash Flow
All numbers in Millions USD
Black Diamond Therapeutics News & Key Events
Today's Timeline - 03 December
Wed, 08:33 PM
-Black Diamond shares drop 28% after reporting Phase 2 data for Silevertinib in NSCLC and plans for GBM trial.
Insights on Black Diamond Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.6% return, outperforming this stock by 6.3%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 68.7% return, outperforming this stock by 42.5%
NEGATIVE IMPACTPrice Dip
In the last 3 months, BDTX stock has moved down by -20.0%
About Black Diamond Therapeutics
| Organisation | Black Diamond Therapeutics |
| Headquarters | One Main Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Dr. Mark A. Velleca M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Black Diamond Therapeutics
Name | Title |
|---|---|
Ms. Melanie Morrison | Chief Development Officer |
Dr. Mark A. Velleca M.D., Ph.D. | CEO, President & Chairman |
Mr. Brent Hatzis-Schoch Esq., J.D. | COO & General Counsel |
Dr. Sergey Yurasov M.D., Ph.D. | Chief Medical Officer |
Dr. Elizabeth Buck Ph.D. | Co-Founder & Chief Scientific Officer |
Ms. Erika Jones | Principal Financial Officer, Principal Accounting Officer, SVP of Finance & Corporate Controller |
FAQs
What is Black Diamond Therapeutics share price today?
Black Diamond Therapeutics share price today is $2.13 as on at the close of the market. Black Diamond Therapeutics share today touched a day high of $2.22 and a low of $2.07.
What is the 52 week high and 52 week low for Black Diamond Therapeutics share?
Black Diamond Therapeutics share touched a 52 week high of $4.94 on and a 52 week low of $1.2 on . Black Diamond Therapeutics stock price today i.e. is closed at $2.13,which is 56.88% down from its 52 week high and 78.24% up from its 52 week low.
What is Black Diamond Therapeutics's market capitalisation today?
Black Diamond Therapeutics market capitalisation is $0.00T as on .
How to invest in Black Diamond Therapeutics Stock (BDTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Black Diamond Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Black Diamond Therapeutics Shares that will get you 0.7042 shares as per Black Diamond Therapeutics share price of $2.13 per share as on March 14, 2026 at 1:29 am IST.
What is the minimum amount required to buy Black Diamond Therapeutics Stock (BDTX) from India?
Indian investors can start investing in Black Diamond Therapeutics (BDTX) shares with as little as ₹92.45 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹924.50 in Black Diamond Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Black Diamond Therapeutics share’s latest price of $2.13 as on March 14, 2026 at 1:29 am IST, you will get 4.6948 shares of Black Diamond Therapeutics. Learn more about
fractional shares .
What are the returns that Black Diamond Therapeutics has given to Indian investors in the last 5 years?
Black Diamond Therapeutics stock has given -92% share price returns and 27.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?